UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 395

Sortiert nach

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Nature communications, 2018-02, Vol.9 (1), p.741-14, Article 741

2018

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive review on posttreatment surveillance in colorectal patients

Polskie archiwum medycyny wewne̦trznej, 2021-03, Vol.131 (3), p.276-287

Wysocki, Piotr T

2021

Link zum Volltext

Verfügbarkeit prüfen

lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells

Endocrine-related cancer, 2023-08, Vol.30 (8)

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer-A Nation-Wide Study

International journal of molecular sciences, 2023-05, Vol.24 (10), p.9073

2023

Link zum Volltext

Verfügbarkeit prüfen

Jak kropla na kamień...”. Lokalna działalność rodziny Tarczyńskich jako przykład pracy na rzecz niepodległości Polski

Studia z historii społeczno-gospodarczej XIX i XX wieku, 2018-06, Vol.19 (19), p.169-190

Wysocki, Piotr

2018

Link zum Volltext

Verfügbarkeit prüfen

Adenoid cystic carcinoma: emerging role of translocations and gene fusions

Oncotarget, 2016-10, Vol.7 (40), p.66239-66254

2016

Link zum Volltext

Verfügbarkeit prüfen

Discovery and development of differentially methylated regions in human papillomavirus‐related oropharyngeal squamous cell carcinoma

International journal of cancer, 2018-11, Vol.143 (10), p.2425-2436

2018

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data

Journal of clinical medicine, 2023-02, Vol.12 (4), p.1350

2023

Link zum Volltext

Verfügbarkeit prüfen

mTOR in renal cell cancer: modulator of tumor biology and therapeutic target

Expert review of molecular diagnostics, 2009-04, Vol.9 (3), p.231-241

Wysocki, Piotr J

2009

Link zum Volltext

Verfügbarkeit prüfen

Common pathway signature in lung and liver fibrosis

Cell cycle (Georgetown, Tex.), 2016-07, Vol.15 (13), p.1667-1673

2016

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer

Cancers, 2023-02, Vol.15 (4), p.1067

2023

Link zum Volltext

Verfügbarkeit prüfen

Progress in the treatment of bone metastases in cancer patients

Expert opinion on investigational drugs, 2012-06, Vol.21 (6), p.785-795

2012

Link zum Volltext

Verfügbarkeit prüfen

Elemental Characterization of Ciders and Other Low-Percentage Alcoholic Beverages Available on the Polish Market

Molecules (Basel, Switzerland), 2021-04, Vol.26 (8), p.2186

2021

Link zum Volltext

Verfügbarkeit prüfen

Advancing toward a molecular characterization of polymorphous low grade adenocarcinoma

Oral oncology, 2017-11, Vol.74, p.192-193

2017

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Chemotherapy in Prostate Cancer

Journal of clinical medicine, 2022-05, Vol.11 (10), p.2853

2022

Link zum Volltext

Verfügbarkeit prüfen

The Elemental Profile of Beer Available on Polish Market: Analysis of the Potential Impact of Type of Packaging Material and Risk Assessment of Consumption

Molecules (Basel, Switzerland), 2022-05, Vol.27 (9), p.2962

2022

Link zum Volltext

Verfügbarkeit prüfen

Complete remission of hypercortisolemia in patient with severe ectopic Cushing's syndrome due to small cell lung cancer

Polskie archiwum medycyny wewne̦trznej, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin

Expert review of molecular diagnostics, 2010-05, Vol.10 (4), p.509-519

2010

Link zum Volltext

Verfügbarkeit prüfen

Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer Patients

Journal of clinical medicine, 2021-08, Vol.10 (17), p.3902

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab

Frontiers in pharmacology, 2023-03, Vol.13, p.1063178-1063178

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer

Journal of clinical medicine, 2022-02, Vol.11 (5), p.1213

2022

Link zum Volltext

Verfügbarkeit prüfen

Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol

The breast journal, 2021-10, Vol.27 (10), p.781-786

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 395

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(365)
Mit Volltextzugriff
(354)

Publikationsform

Sprache

Englisch
(370)
Polnisch
(59)
Japanisch
(19)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

A comprehensive review on posttreatment surveillance in colorectal patients

Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline

lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells

Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer-A Nation-Wide Study

Jak kropla na kamień...”. Lokalna działalność rodziny Tarczyńskich jako przykład pracy na rzecz niepodległości Polski

Adenoid cystic carcinoma: emerging role of translocations and gene fusions

Discovery and development of differentially methylated regions in human papillomavirus‐related oropharyngeal squamous cell carcinoma

Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data

mTOR in renal cell cancer: modulator of tumor biology and therapeutic target

Common pathway signature in lung and liver fibrosis

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer

Progress in the treatment of bone metastases in cancer patients

Elemental Characterization of Ciders and Other Low-Percentage Alcoholic Beverages Available on the Polish Market

Advancing toward a molecular characterization of polymorphous low grade adenocarcinoma

Metronomic Chemotherapy in Prostate Cancer

The Elemental Profile of Beer Available on Polish Market: Analysis of the Potential Impact of Type of Packaging Material and Risk Assessment of Consumption

Complete remission of hypercortisolemia in patient with severe ectopic Cushing's syndrome due to small cell lung cancer

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin

Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer Patients

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab

Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer

Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

Suchergebnisse filtern